Church & Dwight Co., Inc. (NYSE:CHD) Stake Lessened by Eads & Heald Wealth Management

Eads & Heald Wealth Management decreased its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 0.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,969 shares of the company’s stock after selling 160 shares during the quarter. Church & Dwight accounts for approximately 1.2% of Eads & Heald Wealth Management’s holdings, making the stock its 20th biggest position. Eads & Heald Wealth Management’s holdings in Church & Dwight were worth $2,510,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the business. Capital Performance Advisors LLP purchased a new stake in shares of Church & Dwight during the 3rd quarter worth about $27,000. Ashton Thomas Securities LLC bought a new position in Church & Dwight during the third quarter valued at approximately $28,000. Versant Capital Management Inc lifted its stake in Church & Dwight by 224.4% in the fourth quarter. Versant Capital Management Inc now owns 266 shares of the company’s stock valued at $28,000 after acquiring an additional 184 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in Church & Dwight in the second quarter worth approximately $33,000. Finally, Kimelman & Baird LLC acquired a new position in shares of Church & Dwight during the 2nd quarter worth $46,000. 86.60% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CHD shares. Stifel Nicolaus reduced their price objective on shares of Church & Dwight from $105.00 to $103.00 and set a “hold” rating for the company in a research note on Friday, January 17th. Wells Fargo & Company boosted their price target on Church & Dwight from $113.00 to $115.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. TD Cowen increased their price objective on Church & Dwight from $114.00 to $117.00 and gave the company a “buy” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft boosted their target price on Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Finally, Piper Sandler increased their price target on Church & Dwight from $124.00 to $128.00 and gave the company an “overweight” rating in a report on Monday, January 6th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, Church & Dwight presently has a consensus rating of “Hold” and a consensus target price of $110.61.

Insider Buying and Selling at Church & Dwight

In other news, EVP Michael Read purchased 1,100 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were bought at an average cost of $106.82 per share, for a total transaction of $117,502.00. Following the completion of the acquisition, the executive vice president now directly owns 2,505 shares in the company, valued at approximately $267,584.10. This trade represents a 78.29 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Joseph James Longo sold 7,780 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $112.44, for a total value of $874,783.20. Following the transaction, the chief accounting officer now owns 400 shares of the company’s stock, valued at approximately $44,976. The trade was a 95.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 593,035 shares of company stock valued at $62,282,808. Company insiders own 1.40% of the company’s stock.

Church & Dwight Stock Performance

CHD stock opened at $106.66 on Wednesday. Church & Dwight Co., Inc. has a twelve month low of $96.09 and a twelve month high of $113.50. The company has a quick ratio of 1.09, a current ratio of 1.62 and a debt-to-equity ratio of 0.53. The company has a market cap of $26.13 billion, a P/E ratio of 47.83, a price-to-earnings-growth ratio of 3.28 and a beta of 0.58. The business’s fifty day moving average is $106.84 and its 200-day moving average is $104.04.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings results on Friday, November 1st. The company reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.68 by $0.11. The business had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. Church & Dwight had a net margin of 9.08% and a return on equity of 19.90%. Church & Dwight’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period last year, the company posted $0.74 EPS. Equities research analysts forecast that Church & Dwight Co., Inc. will post 3.44 EPS for the current year.

Church & Dwight Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 2nd. Shareholders of record on Friday, November 15th were issued a dividend of $0.2838 per share. The ex-dividend date was Friday, November 15th. This represents a $1.14 annualized dividend and a yield of 1.06%. Church & Dwight’s dividend payout ratio is presently 50.67%.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.